The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$2.5 million per quarter. This data-driven, fact-based tracker will continually update based on new financial filings so that readers can stay up to date. Companies must file with the SEC or SEDAR to be considered for inclusion. Please note that we plan to raise the minimum quarterly revenue in May to US$5 million.
44 companies currently qualify for inclusion, with 27 filing in U.S dollars and 17 in the Canadian currency. Since our last report in mid-March, we have removed Surna (OTC: SRNA) and have added United Cannabis (OTC: CNAB). We expect to add several companies in the coming months, including TILT Holdings (CSE: TILT) (OTC: TILTF), which announced very strong January pro forma revenue and is likely to qualify for its Q4, which should be reported in April.
In late March, Charlotte’s Web (CSE: CWEB) (OTC: CWBHF), Curaleaf Holdings (CSE: CURA) (OTC: CURLF), Tilray (NASDAQ: TLRY) and United Cannabis reported their Q4 financials. Charlotte’s Web saw sales jump 21% from Q3. Curaleaf moved to the top spot with its $32 million quarter. The company reaffirmed its outlook for $400 million in revenue in 2019. Tilray revenue was ahead of expectations, growing 55% from the prior quarter, but their margins were pressured. United Cannabis made the list for the first time after generating $3 million in sales of CBD products derived from industrial hemp.
U.S Dollar Reporting – Public Cannabis Company Revenue Tracker
Several companies are expected to report in April, including Cannex Capital (CSE: CNNX) (OTC: CNXXF), Cresco Labs (CSE: CL) (OTC: CRLBF), Golden Leaf Holdings (CSE: GLH) (OTC: GLDFF), Green Thumb Industries (CSE: GTII) (OTC: GTBIF), which has scheduled a call for April 9th, GrowGeneration (OTC: GRWG), which will host a call on April 1 after the market closes, Halo Labs, (NEO: HALO) (OTC: AGEEF), Harvest Health & Recreation (CSE: HARV) (OTC: HRVSF), Helix TCS (OTC: HLIX), which will host a call on April 4th, KushCo Holdings (OTC: KSHB), Marimed (OTC: MRMD), Medicine Man Technologies (OTC: MDCL), MJardin Group (CSE: MJAR) (OTC: MJARF), Planet 13 Holdings (CSE: PLTH) (OTC: PLNHF), Plus Products (CSE: PLUS) (OTC: PLPRF) and Trulieve (CSE: TRUL) (OTC: TCNNF). According to Sentieo, Trulieve is expected to have generated sales of $32.5 million in Q4, which will put it at the top of the list. KushCo Holdings is expected to have generated sales of $25.5 million in its fiscal Q2 ending February 28th. GTI is expected to have generated sales of $20.5 million during Q4. Plus Products recently pre-announced Q4 sales at $3.4 million.
Of the companies that report in Canadian dollars, CannTrust (TSX: TRST) (NYSE: CTST) and Cronos Group (TSX: CRON) (NASDAQ: CRON) reported just last week, with both companies disappointing the market with sales that fell below expectations.
Canadian Dollar Reporting – Public Cannabis Company Revenue Tracker
In April, we expect reports from 1933 Industries (CSE: TGIF) (OTC: TGIFF), Aphria (TSX: APHA) (NYSE: APHA), Namaste Technologies (TSXV: N) (OTC: NXTTF), National Access Cannabis (TSXV: META) (OTC: NACNF), Nutritional High (CSE: EAT) (OTC: SPLIF), Organigram (TSXV: OGI) (OTC: OGRMF) Origin House (CSE: OH) (OTC: ORHOF) and Sunniva (CSE: SNN) (OTC:SNNVF). According to Sentieo, Aphria is expected to report Q3 sales of C$63.8 million, while Organigram is expected to have generated Q2 sales of C$17.8 million, though the company had previously indicated that it expected net revenue to be in excess of C$24.8 million. Origin House is expected to have generated Q4 revenue of C$12.0 million.
Visit the Public Cannabis Company Revenue Tracker to track and explore the complete list of qualifying companies. For our readers who are interested in staying on top of scheduled earnings calls in the sector, we have recently introduced the Cannabis Investor Earnings Conference Call Calendar.
